This article has been cited by
1Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt
Mohsen A. Gadallah,Alaa Mokhtar,Mervat Rady,Essam El-Moghazy,Magdy Fawzy,Sahar Khalil Kandil
Journal of the Formosan Medical Association.2016;115(11)997
[DOI]
2Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India
Malaisamy Muniyandi,Rajeswari Ramachandran
Expert Opinion on Pharmacotherapy.2017;18(13)1301
[DOI]
3Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies
Kelemu Tilahun Kibret,Yonatan Moges,Peter Memiah,Sibhatu Biadgilign
Infectious Diseases of Poverty.2017;6(1)1301
[DOI]
4An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis
Mayara Lisboa Bastos,Zhiyi Lan,Dick Menzies
European Respiratory Journal.2017;49(3)1600803
[DOI]
5Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis
Kefyalew Addis Alene,Archie C A Clements,Emma S McBryde,Ernesto Jaramillo,Knut Lönnroth,Debebe Shaweno,Amelia Gulliver,Kerri Viney
Journal of Infection.2018;77(5)357
[DOI]
6Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
Jia Yin,Jinqiu Yuan,Yanhong Hu,Xiaolin Wei,Pere-Joan Cardona
PLOS ONE.2016;11(3)e0150511
[DOI]
7Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China
Caihong Xu,Yu Pang,Renzhong Li,Yunzhou Ruan,Lixia Wang,Mingting Chen,Hui Zhang
Journal of Infection.2018;76(4)348
[DOI]
8Cigarette Smoking Impairs Human Pulmonary Immunity toMycobacterium tuberculosis
Seónadh M. O’Leary,Michelle M. Coleman,Wui Mei Chew,Colette Morrow,Anne Marie McLaughlin,Laura E. Gleeson,Mary P. O’Sullivan,Joseph Keane
American Journal of Respiratory and Critical Care Medicine.2014;190(12)1430
[DOI]
9Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China
Xubin Zheng,Rongrong Zheng,Yi Hu,Jim Werngren,Lina Davies Forsman,Mikael Mansjö,Biao Xu,Sven Hoffner
Antimicrobial Agents and Chemotherapy.2016;60(8)4786
[DOI]
10Factors predicting treatment success in multi-drug resistant tuberculosis patients treated under programmatic conditions
A.K. Janmeja,Deepak Aggarwal,Ruchika Dhillon
Indian Journal of Tuberculosis.2018;65(2)135
[DOI]
11Efficacy and effect of free treatment on multidrug-resistant tuberculosis
QING ZHANG,ZHEYUAN WU,ZURONG ZHANG,WEI SHA,XIN SHEN,HEPING XIAO
Experimental and Therapeutic Medicine.2016;11(3)777
[DOI]
12Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis
Joel Philip Samuels,Aashna Sood,Jonathon R. Campbell,Faiz Ahmad Khan,James Cameron Johnston
Scientific Reports.2018;8(1)777
[DOI]
13Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant tuberculosis, Tamil Nadu, India
Dina Nair,Pooranaganga D. Navneethapandian,Jaya Prasad Tripathy,Anthony D. Harries,Joel S. Klinton,Basilea Watson,Gomathi N. Sivaramakrishnan,Devarajulu S. Reddy,Lakshmi Murali,Mohan Natrajan,Soumya Swaminathan
Transactions of The Royal Society of Tropical Medicine and Hygiene.2016;110(9)534
[DOI]
14Study of factors influencing response and outcome of Cat-IV regimen in MDRTB patients
Arun Kumar Yadav,Ashok Kumar Mehrotra,S.P. Agnihotri,Shivani Swami
Indian Journal of Tuberculosis.2016;63(4)255
[DOI]
15Reactions to Antituberculous Drugs and Desensitization Treatment
Josefina Cernadas,Eduardo Cernadas
Current Treatment Options in Allergy.2019;63(4)255
[DOI]
  Feedback 
  Subscribe